49 related articles for article (PubMed ID: 8050257)
1. Influence of prenatal cocaine exposure on early language development: longitudinal findings from four months to three years of age.
Morrow CE; Bandstra ES; Anthony JC; Ofir AY; Xue L; Reyes MB
J Dev Behav Pediatr; 2003 Feb; 24(1):39-50. PubMed ID: 12584484
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of intraventricular hemorrhage and developmental delay in cocaine-exposed, very low birth weight infants.
Singer LT; Yamashita TS; Hawkins S; Cairns D; Baley J; Kliegman R
J Pediatr; 1994 May; 124(5 Pt 1):765-71. PubMed ID: 7513757
[TBL] [Abstract][Full Text] [Related]
3. Medical Marijuana Legalization in Oklahoma: Effects on Neonatal Exposure to Opiates.
DeShea L; Rolfs S; McCoy M; Beasley WH; Szyld E; Makkar A
Am J Perinatol; 2024 May; 41(S 01):e1069-e1074. PubMed ID: 36452967
[TBL] [Abstract][Full Text] [Related]
4. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth.
Gray TR; Eiden RD; Leonard KE; Connors GJ; Shisler S; Huestis MA
Clin Chem; 2010 Sep; 56(9):1442-50. PubMed ID: 20628142
[TBL] [Abstract][Full Text] [Related]
5. Relationship of prenatal cocaine exposure and maternal postpartum psychological distress to child developmental outcome.
Singer L; Arendt R; Farkas K; Minnes S; Huang J; Yamashita T
Dev Psychopathol; 1997; 9(3):473-89. PubMed ID: 9327234
[TBL] [Abstract][Full Text] [Related]
6. NEONATAL VISUAL INFORMATION PROCESSING IN COCAINE-EXPOSED AND NON-EXPOSED INFANTS.
Singer LT; Arendt R; Fagan J; Minnes S; Salvator A; Bolek T; Becker M
Infant Behav Dev; 1999; 22(1):1-15. PubMed ID: 25717215
[TBL] [Abstract][Full Text] [Related]
7. Medical and Psychologic Risks of Maternal Cocaine Use.
Singer L; Arendt RE; Minnes S; Garber RM
Resid Staff Physician; 1997 Oct; 43(10):55-65. PubMed ID: 25568499
[TBL] [Abstract][Full Text] [Related]
8. Disentangling the Correlates of Drug Use in a Clinic and Community Sample: A Regression Analysis of the Associations between Drug Use, Years-of-School, Impulsivity, IQ, Working Memory, and Psychiatric Symptoms.
Heyman GM; Dunn BJ; Mignone J
Front Psychiatry; 2014; 5():70. PubMed ID: 25009508
[TBL] [Abstract][Full Text] [Related]
9. Prenatal substance exposure: neurobiologic organization at 1 month.
Conradt E; Sheinkopf SJ; Lester BM; Tronick E; LaGasse LL; Shankaran S; Bada H; Bauer CR; Whitaker TM; Hammond JA;
J Pediatr; 2013 Oct; 163(4):989-94.e1. PubMed ID: 23743094
[TBL] [Abstract][Full Text] [Related]
10. A biomarker validation study of prenatal chlorpyrifos exposure within an inner-city cohort during pregnancy.
Whyatt RM; Garfinkel R; Hoepner LA; Andrews H; Holmes D; Williams MK; Reyes A; Diaz D; Perera FP; Camann DE; Barr DB
Environ Health Perspect; 2009 Apr; 117(4):559-67. PubMed ID: 19440494
[TBL] [Abstract][Full Text] [Related]
11. Cocaine and opioid use during pregnancy: prevalence and management.
Bhuvaneswar CG; Chang G; Epstein LA; Stern TA
Prim Care Companion J Clin Psychiatry; 2008; 10(1):59-65. PubMed ID: 18311423
[No Abstract] [Full Text] [Related]
12. Cocaine use as a risk factor for abdominal pregnancy.
Audain L; Brown WE; Smith DM; Clark JF
J Natl Med Assoc; 1998 May; 90(5):277-83. PubMed ID: 9617068
[TBL] [Abstract][Full Text] [Related]
13. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.
Lester BM; ElSohly M; Wright LL; Smeriglio VL; Verter J; Bauer CR; Shankaran S; Bada HS; Walls HH; Huestis MA; Finnegan LP; Maza PL
Pediatrics; 2001 Feb; 107(2):309-17. PubMed ID: 11158464
[TBL] [Abstract][Full Text] [Related]
14. Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation.
Ostrea EM; Ostrea AR; Simpson PM
Pediatrics; 1997 Jul; 100(1):79-83. PubMed ID: 9200364
[TBL] [Abstract][Full Text] [Related]
15. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
16. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health.
Koren G; Hutson J; Gareri J
Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086
[TBL] [Abstract][Full Text] [Related]
17. Determination of drugs of abuse in meconium.
Moore C; Negrusz A; Lewis D
J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(1):137-46. PubMed ID: 9700556
[TBL] [Abstract][Full Text] [Related]
18. Neonatal outcome in infants with evidence of fetal exposure to opiates, cocaine, and cannabinoids.
Nair P; Rothblum S; Hebel R
Clin Pediatr (Phila); 1994 May; 33(5):280-5. PubMed ID: 8050257
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
